Works Cited
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
1. Federation of State Medical Boards. Strategies for Prescribing Opioids for the Management of Pain. Available at https://www.fsmb.org/siteassets/advocacy/policies/strategies-for-prescribing-opioids-for-the-management-of-pain.pdf. Last accessed July 13, 2026.
2. Institute of Medicine, Committee on Advancing Pain Research, Care, and Education. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, DC: The National Academies Press; 2011.
3. PR Newswire. U.S. Public and Doctors' Misperceptions Revealed in National Survey Demonstrate Urgent Need for Increased Opioid Dependence Awareness. Available at https://www.prnewswire.com/news-releases/us-public-and-doctors-misperceptions-revealed-in-national-survey-demonstrate-urgent-need-for-increased-opioid-dependence-awareness-210981471.html. Last accessed July 16, 2026.
4. Reed S. Addiction Vs. Dependence. Available at https://www.addictioncenter.com/addiction/addiction-vs-dependence/. Last accessed July 16, 2026.
5. Bhamb B, Brown D, Hariharan J, et al. Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain. Curr Med Res Opin. 2006;22(9):1859-1865.
6. Mezei L, Murinson BB. Pain education in North American medical schools. J Pain. 2011;12:1199-1208.
7. Vadivelu N, Mitra S, Hines R, Elia M, Rosenquist R. Acute pain in undergraduate medical education: an unfinished chapter! Pain Pract. 2012;12(8):663-671.
8. Oliver J, Coggins C, Compton P, et al. American Society for Pain Management Nursing position statement: pain management in patients with substance use disorders. Pain Manage Nurs. 2012;13(3):169-183.
9. Psychiatry Online. Highlights of Changes from DSM-IV-TR to DSM-5. Available at https://www.psychiatry.org/File Library/Psychiatrists/Practice/DSM/APA_DSM_Changes_from_DSM-IV-TR_-to_DSM-5.pdf. Last accessed July 13, 2026.
10. American Society of Addiction Medicine. Definition of Addiction. Available at https://www.asam.org/docs/default-source/quality-science/asam's-2019-definition-of-addiction-(1).pdf?sfvrsn=b8b64fc2_2. Last accessed July 13, 2026.
11. Reuben DB, Alvanzo AAH, Ashikaga T, et al. National Institutes of Health Pathways to Prevention Workshop: the role of opioids in the treatment of chronic pain. Ann Intern Med. 2015;162(4):295-300.
12. Giordano J, Schatman ME, Höver G. Ethical insights to rapprochement in pain care: bringing stakeholders together in the best interest(s) of the patient. Pain Physician. 2009;12:E265-E275.
13. Atkinson TJ, Schatman ME, Fudin J. The damage done by the war on opioids: the pendulum has swung too far. J Pain Res. 2014;7:265-268.
16. Schatman ME, Webster LR. The health insurance industry: perpetuating the opioid crisis through policies of cost-containment and profitability. J Pain Res. 2015;8:153-158.
17. Fudin J, Pratt Cleary J, Schatman ME. The MEDD myth: the impact of pseudoscience on pain research and prescribing-guideline development. J Pain Res. 2016;9:153-156.
18. Centers for Disease Control and Prevention. Annual Surveillance Report of Drug-Related Risks and Outcomes: United States, 2019. Available at https://www.cdc.gov/overdose-prevention/media/pdfs/pubs/2019-cdc-drug-surveillance-report.pdf. Last accessed July 13, 2026.
19. Jamison RN, Scanlan E, Matthews ML, Jurcik DC, Ross EL. Attitudes of primary care practitioners in managing chronic pain patients prescribed opioids for pain: a prospective longitudinal controlled trial. Pain Med. 2016;17(1):99-113.
20. Cohen C, Robles-Fradet A. Reducing Opioid Prescriptions Does Not Reduce Overdoses, But It Does Harm Low-Income Pain Patients. Available at https://healthlaw.org/reducing-opioid-prescriptions-does-not-reduce-overdoses-but-it-does-harm-low-income-pain-patients/. Last accessed July 16, 2026.
21. Kenen K, Mack K, Paulozzi L. Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000–2010. Open Med. 2012;6(2)e41-e47.
22. International Narcotics Control Board. Narcotic Drugs, 2025: Estimated World Requirements for 2026. Available at https://www.incb.org/incb/uploads/documents/Narcotic-Drugs/Technical-Publications/2025/NarcoticDrugs2025-eBook.pdf. Last accessed July 16, 2026.
23. Bhadelia A, De Lima L, Arreola-Ornelas H, Kwete XJ, Rodriquez NM, Knaul FM. Solving the global crisis in access to pain relief: lessons from country actions. Am J Public Health. 2019;109(1):58-60.
24. Carney T, Van Hout MC, Norman I, Dada S, Siegfried N, Parry CDH. Dihydrocodeine for detoxification and maintenance treatment in individuals with opiate use disorders. Cochrane Database Syst Rev. 2020;(2):CD012254.
25. National Institute on Drug Abuse. Drug Overdose Deaths. Available at https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates. Last accessed July 16, 2026.
26. Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011;171(7):686-691.
27. Dasgupta N, Funk MJ, Proescholdbell S, Hirsch A, Ribisl KM, Marshall S. Cohort study of the impact of high-dose opioid analgesics on overdose mortality. Pain Med. 2016;17(1):85-98.
28. Agarwal SD, Landon BE. Patterns in outpatient benzodiazepine prescribing in the United States. JAMA Netw Open. 2019;2(1):e1873999.
29. Florida Department of Health. Prescription Drug Monitoring Program Annual Report: Fiscal Year 2020-2021. Available at https://www.floridahealth.gov/statistics-and-data/e-forcse/news-reports/_documents/annual-report-2021.pdf. Last accessed July 16, 2026.
30. Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths—United States, 2000–2014. MMWR. 2016;64(50):1378-1382.
31. Florida Department of Law Enforcement. Drugs Identified in Deceased Persons by Florida Medical Examiners: 2023 Annual Report. Available at https://www.myfloridalegal.com/sites/default/files/2025-01/2023-drugs-in-deceased-annual-report.pdf. Last accessed July 13, 2026.
32. Johnson H, Paulozzi L, Porucznik C, Mack K, Herter B. Decline in drug overdose deaths after state policy changes—Florida, 2010–2012. MMWR. 2014;63(26):569-574.
33. Florida Orthopedic Society. Gov. Scott Declares State of Emergency For Opioid Epidemic. Available at https://floridaorthopaedicsociety.org/news/news.asp?id=343570. Last accessed July 13, 2026.
34. Ron DeSantis, 46th Governor of Florida. 2018 Executive Orders. #2018-362 Executive Order Extends Executive Order 18-279 Re: Opioid Epidemic: December 5, 2018. Available at https://www.flgov.com/eog/news/executive-orders/2019-36. Last accessed July 13, 2026.
35. Hall J. Florida Drug Trends Update: November 2015. Available at https://slideplayer.com/slide/12804922/. Last accessed July 16, 2026.
36. Popovich N. A Deadly Crisis: Mapping the Spread of America's Drug Overdose Epidemic. Available at https://www.theguardian.com/society/ng-interactive/2016/may/25/opioid-epidemic-overdose-deaths-map. Last accessed July 16, 2026.
37. Jones CM, Paulozzi LJ, Mack KA. Alcohol involvement in opioid pain reliever and benzodiazepine drug abuse-related emergency department visits and drug-related deaths—United States, 2010. MMWR. 2014;63(40):881-885.
38. Ruhm CJ. Drug poisoning deaths in the United States, 1999–2012: a statistical adjustment analysis. Popul Health Metr. 2016;14:2.
39. Scott J. Florida's New Law on Controlled Substance Prescribing. Available at https://flmedical.org/Florida/Florida_Public/Docs/FMA-Opioid-HB21.pdf. Last accessed July 16, 2026.
40. Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC clinical practice guideline for prescribing opioids for pain--United States, 2022. MMWR. 2022;71(RR3):1-95.
41. Webster L. Will CDC Opioid Guidelines Help Reduce Overdoses? Available at https://www.painnewsnetwork.org/stories/2016/4/25/will-cdc-opioid-guidelines-help-reduce-overdoses. Last accessed July 14, 2026.
42. Peachman RR. Will the new CDC opioid prescribing guidelines help correct the course in pain care? JAMA. 2023;329(2):111-113.
43. Samp RA. Letter to the CDC ATS DR. Available at https://s3.us-east-2.amazonaws.com/washlegal-uploads/upload/litigation/misc/CDCFOIARequest-Opioids.pdf. Last accessed July 16, 2026.
44. Kroenke K, Alford DP, Argoff C, et al. Challenges with implementing the Centers for Disease Control and Prevention opioid guideline: a consensus panel report. Pain Med. 2019;20(4):724-735.
45. Association of American Medical Colleges. Addiction Medicine, Substance Use, and Pain Management in Medical School Curricula. Available at https://www.aamc.org/media/83346/download?attachment. Last accessed July 13, 2026.
46. Lucas JW, Sohi I. Chronic Pain and High-impact Chronic Pain in U.S. Adults, 2023. Available at https://www.cdc.gov/nchs/products/databriefs/db518.htm. Last accessed July 13, 2026.
47. Centers for Disease Control and Prevention. Opioid Dispensing Rate Maps. Available at https://www.cdc.gov/overdose-prevention/data-research/facts-stats/opioid-dispensing-rate-maps.html. Last accessed July 13, 2026.
48. Alford DP. Opioid prescribing for chronic pain: achieving the right balance through education. N Engl J Med. 2016;374(4):301-303.
49. Wallwork RS, Chipidza FE, Stern TA. Obstacles to the prescription and use of opioids. Prim Care Companion CNS Disord. 2016;18(1):10.
50. U.S. Department of Veterans Affairs. VA/DoD Clinical Practice Guidelines: Use of Opioids in the Management of Chronic Pain (2022). Available at https://www.healthquality.va.gov/guidelines/Pain/cot/. Last accessed July 16, 2026.
51. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113-130.
52. The Florida Senate. CS/CS/HB 21: Controlled Substances. Available at https://www.flsenate.gov/Session/Bill/2018/21. Last accessed July 14, 2026.
53. Argoff CE, Silvershein DI. A comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring therapy to meet patient needs. Mayo Clin Proc. 2009;84(7):602-612.
54. McCarberg BH, Barkin RL. Long-acting opioids for chronic pain: pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesia. Am J Ther. 2001;8(3):181-186.
55. National Comprehensive Cancer Network. Adult Cancer Pain, V.2.2026. Available at https://www.nccn.org/professionals/physician_gls/pdf/pain.pdf. Last accessed July 14, 2026.
56. Florida Board of Medicine. Florida Statutes and Administrative Codes: Florida Administrative Codes: Chapter 64B8: Board of Medicine: Rule Chapter: 64B8-9: Rule No. 64B8-9.013 Standards for the Prescribing of Controlled Substances for the Treatment of Acute Pain. Available at https://flrules.org/gateway/RuleNo.asp?title=STANDARDS OF PRACTICE FOR MEDICAL DOCTORS&ID=64B8-9.013. Last accessed July 14, 2026.
57. Utah Department of Health, Utah Medical Association. Utah Clinical Guidelines on Prescribing Opioids for Treatment of Pain: 2018. Available at https://vipp.health.utah.gov/wp-content/uploads/Opioid-Clinical-Guidelines.pdf. Last accessed July 14, 2026.
58. Sloan P. Update on extended-release opioids in pain management. Expert Opin Drug Deliv. 2014;11(2):155-158.
59. Federation of State Medical Boards. Model Policy for the Use of Opioid Analgesics in the Treatment of Chronic Pain. Washington, DC: Federation of State Medical Boards; 2013.
60. Cheatle MD, Barker C. Improving opioid prescription practices and reducing patient risk in the primary care setting. J Pain Res. 2014;7:301-311.
61. Nadeau SE. Opioids for chronic noncancer pain. To prescribe or not to prescribe: what is the question? Neurology. 2015;85(7):646-651.
62. U.S. Food and Drug Administration. Guidance: Medication Guides: Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS). Available at https://www.fda.gov/media/79776/download. Last accessed July 14, 2026.
63. Manchikanti L, Abdi S, Atluri S, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2—guidance. Pain Physician. 2012;15(3 Suppl):S67-S116.
64. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool. Pain Med. 2005;6(6):432-442.
65. Opioid Risk Tool. Available at https://nida.nih.gov/sites/default/files/opioidrisktool.pdf. Last accessed July 14, 2026.
66. Butler SF, Budman SH, Fernandez KC, Fanciullo GJ, Jamison RN. Cross-validation of a Screener to Predict Opioid Misuse in Chronic Pain Patients (SOAPP-R). J Addict Med. 2009;3(2):66-73.
67. Screener and Opioid Assessment for Patients with Pain (SOAPP) Version 1.0-SF. Available at https://www.mcstap.com/docs/SOAPP-5.pdf. Last accessed July 14, 2026.
68. Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2004.
69. Johns Hopkins Medicine. CAGE-AID Substance Abuse Screening Tool. Available at https://www.hopkinsmedicine.org/-/media/johns-hopkins-health-plans/documents/all_plans/cage-substance-screening-tool.pdf. Last accessed July 14, 2026.
70. Fine PG, Finnegan T, Portenoy RK. Protect your patients, protect your practice: practical risk assessment in the structuring of opioid therapy in chronic pain. J Fam Pract. 2010;59(9 Suppl 2):S1-S16.
71. DIRE Score: Patient Selection for Chronic Opioid Analgesia. Available at https://amdg.wa.gov/Files/AssessmentTools/11-DIRE_score.pdf. Last accessed July 16, 2026.
72. Katz NP. Opioid Prescribing Toolkit: A Workbook for Clinicians. New York, NY: Oxford University Press; 2010.
73. Dalal S, Bruera E. Assessment and management of pain in the terminally ill. Prim Care Clin Office Pract. 2011;38(2):195-223.
74. Berger AM, Shuster JL, Von Roenn JH (eds). Principles & Practice of Palliative Care & Supportive Oncology. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2013.
75. Matteliano D, St. Marie BJ, Oliver J. Adherence monitoring with chronic opioid therapy for persistent pain: a biopsychosocial-spiritual approach to mitigate risk. Pain Manag Nurs. 2014;15(1):391-405.
76. Strickland JM, Huskey A, Brushwood DB. Pharmacist-physician collaboration in pain management practice. J Opioid Manag. 2007;3(6): 295-301.
78. Tanzi MG. VIGIL helps pharmacists screen controlled substances: goal is controlling diversion. Pharm Today. 2012:58.
79. Passik SD, Kirsh KL, Whitcomb L, et al. A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther. 2004;26(4):552-561.
80. Center to Advance Palliative Care. Pain Assessment and Documentation Tool. Available at https://www.capc.org/documents/download/38/. Last accessed July 14, 2026.
81. Atluri SL, Akbik H, Sudarshan G. Prevention of opioid abuse in chronic non-cancer pain: an algorithmic, evidence-based approach. Pain Physician. 2012;15(3 Suppl):ES177-ES189.
82. Baxter J. Minimizing the Misuse of Prescription Opioids in Patients with Chronic Nonmalignant Pain. Available at https://nida.nih.gov/sites/default/files/minimizingmisuse_part1.pdf. Last accessed July 16, 2026.
83. American College of Preventive Medicine. ASHP Policy Positions 2009–2026. Available at https://www.ashp.org/-/media/assets/policy-guidelines/docs/browse-by-document-type-policy-positions-with-rationales-pdf.pdf. Last accessed July 16, 2026.
84. Office of National Drug Control Policy. Proper Disposal of Prescription Drugs. Available at https://www.ojp.gov/pdffiles1/ondcp/prescrip_disposal.pdf. Last accessed July 16, 2026.
85. U.S. Food and Drug Administration. Drug Disposal: FDA's Flush List for Certain Medicines. Available at https://www.fda.gov/drugs/disposal-unused-medicines-what-you-should-know/drug-disposal-fdas-flush-list-certain-medicines#FlushList. Last accessed July 16, 2026.
86. Campbell G, Hall WD, Peacock A, et al. Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study. Lancet Public Health. 2018;3(7):e341-e350.
87. Merlin JS, Long D, Becker WC, et al. Marijuana use is not associated with changes in opioid prescriptions or pain severity among people living with HIV and chronic pain. J Acquir Immune Defic Syndr. 2019;81(2):231-237.
88. Mucke M, Phillips T, Radbruch L, Petzke F, Hauser W. Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2018;3:CD012182.
89. Wheeler E, Davidson PJ, Jones TS, Irwin KS. Community-based opioid overdose prevention programs providing naloxone—United States, 2010. MMWR. 2012;61(6):101-105.
90. Florida Legislature. 381.887 Emergency Treatment for Suspected Opioid Overdose. Available at http://www.leg.state.fl.us/statutes/index.cfm?App_mode=Display_Statute&Search_String=&URL=0300-0399/0381/Sections/0381.887.html. Last accessed July 16, 2026.
91. Gutstein HB, Akil H. Opioid analgesics. In: Brunton L, Parker K, Lazo J, Buxton I, Blumenthal D (eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th ed. New York, NY: McGraw-Hill; 2011: 547-590.
92. van den Brink W, Haasen C. Evidence-based treatment of opioid-dependent patients. Can J Psychiatry. 2006;51(10):635-646.
93. Lexicomp Online. Available at https://online.lexi.com/lco/action/login. Last accessed July 16, 2026.
94. Centers for Disease Control and Prevention. Risk for overdose from methadone used for pain relief—United States, 1999–2010. MMWR. 2012;61(26):493-497.
95. U.S. Drug Enforcement Administration. Drug Scheduling. Available at https://www.dea.gov/drug-scheduling. Last accessed July 16, 2026.
96. Florida Legislature. Chapter 893: Drug Abuse Prevention and Control. Available at http://www.leg.state.fl.us/statutes/index.cfm?App_mode=Display_Statute&URL=0800-0899/0893/0893.html. Last accessed July 16, 2026.
97. The 2025 Florida Statutes. Chapter 893: Drug Abuse Prevention and Control: 893.033: Listed Chemicals. Available at http://www.leg.state.fl.us/Statutes/index.cfm?App_mode=Display_Statute&URL=0800-0899/0893/0893.html. Last accessed July 16, 2026.
98. U.S. Department of Justice. Drug Enforcement Administration. Diversion Control Division. ARCOS Retail Drug Summary Reports. Available at https://www.deadiversion.usdoj.gov/arcos/retail_drug_summary/arcos-drug-summary-reports.html. Last accessed July 16, 2026.
99. Substance Abuse and Mental Health Services Administration. Treatment Episode Data Set (TEDS). Available at https://www.samhsa.gov/data/data-we-collect/teds-treatment-episode-data-set. Last accessed July 16, 2026.
100. Centers for Disease Control and Prevention. National Center for Health Statistics. Available at https://www.cdc.gov/nchs/nvss/deaths.htm. Last accessed July 16, 2026.
101. RADARS System. Available at https://www.radars.org/. Last accessed July 16, 2026.
102. Florida Legislature. 893.055 Prescription Drug Monitoring Program. Available at http://www.leg.state.fl.us/statutes/index.cfm?App_mode=Display_Statute&URL=0800-0899/0893/Sections/0893.055.html. Last accessed July 16, 2026.
103. Data Submission Dispenser Guide. Florida Department of Health Prescription Drug Monitoring Program: E-FORCSE: 2023. Available at https://www.floridahealth.gov/wp-content/uploads/2025/07/FLDataSubmissionDispenserGuide_ASAP4.2B_v4.030_final.pdf. Last accessed July 16, 2026.
104. Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2020 National Survey on Drug Use and Health. Available at https://www.samhsa.gov/data/sites/default/files/reports/rpt35325/NSDUHFFRPDFWHTMLFiles2020/2020NSDUHFFR1PDFW102121.pdf. Last accessed July 16, 2026.
105. Sekhon R, Aminjavahery N, Davis CN Jr, et al. Compliance with opioid treatment guidelines for chronic non-cancer pain (CNCP) in primary care at a Veterans Affairs Medical Center (VAMC). Pain Med. 2013;14(10):1548-1556.
106. Meier B. Increase in Urine Testing Raises Ethical Questions. Available at https://www.nytimes.com/2013/08/02/business/increase-in-urine-testing-raises-ethical-questions.html?_r=0. Last accessed July 16, 2026.
107. Passik SD. Issues in long-term opioid therapy: unmet needs, risks, and solutions. Mayo Clin Proc. 2009;84(7):593-601.
108. Holliday S, Hayes C, Dunlop A. Opioid use in chronic non-cancer pain. Part 2: prescribing issues and alternatives. Australian Fam Physician. 2013;42(3):104-111.
109. U.S. Department of Justice Diversion Control Division. Recognizing the Drug Abuser. Available at https://www.deadiversion.usdoj.gov/GDP/(DEA-DC-3) Recognizing the Drug Abuser.pdf. Last accessed July 16, 2026.
110. American Medical Association. Terminating a Patient-Physician Relationship. Code of Medical Ethics: Opinion 1.1.5. Available at https://www.ama-assn.org/delivering-care/terminating-patient-physician-relationship. Last accessed July 16, 2026.
111. Bolen J. Discharging Patients Who Abuse Controlled Substances. Available at https://www.painmedicinenews.com/Policy-Management/Article/04-06/Discharging-Patients-Who-Abuse-Controlled-Substances/4340. Last accessed July 16, 2026.
112. U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services. What is a Prescriber's Role in Preventing the Diversion of Prescription Drugs? Available at https://www.cms.gov/files/document/drugdiversion022316pdf#. Last accessed July 16, 2026.
113. Centers for Disease Control and Prevention. SUDORS Dashboard: Fatal Drug Overdose Data. Available at https://www.cdc.gov/overdose-prevention/data-research/facts-stats/sudors-dashboard-fatal-overdose-data.html. Last accessed July 13, 2026.
114. Florida Department of Health. Prescription Drug Monitoring Program Annual Report: RY-2025. Available at https://www.floridahealth.gov/wp-content/uploads/2026/01/PDMP_Annual_Report_RY25-1.pdf. Last accessed July 13, 2026.
115. U.S. Food and Drug Administration. Drug Disposal: Drug Take-Back Options. Available at https://www.fda.gov/drugs/disposal-unused-medicines-what-you-should-know/drug-disposal-drug-take-back-options. Last accessed July 16, 2026.
116. 2025 Florida Statutes. 465.0276 Dispensing Practitioner. Available at https://www.leg.state.fl.us/statutes/index.cfm?App_mode=Display_Statute&Search_String=&URL=0400-0499/0465/Sections/0465.0276.html. Last accessed July 20, 2026.
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.